Kiromic Biopharma, Inc. Business Finance Contracts & Agreements
40 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Investor Rights Agreements (1)
- Note Agreements (19)
- Purchase Agreements (2)
- Stock Agreements (3)
- Underwriting Agreements (4)
- Warrant Agreements (9)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on January 11, 2024)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on December 15, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on November 6, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on October 2, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on August 29, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on July 27, 2023)
- Form of Exchange Agreement dated as of July 18, 2023 between the Company and the holder of the Exchange Securities (Filed With SEC on July 19, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on June 27, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on May 30, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on April 28, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on March 31, 2023)
- Form of Exchange Agreement dated as of March 28, 2023 between the Company and the holder of the Exchange Securities (Filed With SEC on March 31, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on February 27, 2023)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on January 26, 2023)
- Form of Note Purchase Agreement (Filed With SEC on January 26, 2023)
- Form of the Amended and Restated 25% Senior Secured Convertible Promissory Note (Filed With SEC on December 16, 2022)
- Amended Stipulation of Settlement and Mutual Release, dated October 27, 2022, by and among Kiromic Biopharma, Inc., Sabby Volatility Warrant Master Fund Ltd. and other parties (Filed With SEC on November 2, 2022)
- Form of the 25% Senior Secured Convertible Promissory Note (Filed With SEC on October 27, 2022)
- Standby Equity Purchase Agreement, dated October 13, 2022, by and between Kiromic Biopharma, Inc. and YA II PN, Ltd (Filed With SEC on October 19, 2022)
- Form of the Subordinated Convertible Promissory Note (Filed With SEC on October 14, 2022)
- Stipulation of Settlement and Mutual Release, dated October 10, 2022, by and among Kiromic Biopharma, Inc., Sabby Volatility Warrant Master Fund Ltd. and other parties (Filed With SEC on October 14, 2022)
- Form of Representatives Warrant (Filed With SEC on July 13, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on July 13, 2022)
- Form of Warrant Agent Agreement (Filed With SEC on July 13, 2022)
- Form of Common Stock Warrants (Filed With SEC on July 13, 2022)
- Form of Underwriting Agreement (Filed With SEC on July 13, 2022)
- Form of Representatives Warrant (Filed With SEC on June 25, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 25, 2021)
- Membership Interest Purchase Agreement dated as of June 14, 2021 among Kiromic BioPharma, Inc., In Silico Solution, LLC and Michael Ryan (Filed With SEC on June 17, 2021)
- Form of Representatives Warrant Agreement (Filed With SEC on November 30, 2020)
- Underwriting Agreement, dated October 15, 2020 (Filed With SEC on October 21, 2020)
- Form of Representatives Warrant (Filed With SEC on July 13, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 13, 2020)
- Form of 7% Convertible Promissory Note issued by Kiromic BioPharma, Inc. to certain investors (Filed With SEC on May 11, 2020)
- Form of 17% Convertible Promissory Note issued by Kiromic BioPharma, Inc. to certain investors (Filed With SEC on May 11, 2020)
- Convertible Promissory Note issued by Kiromic BioPharma, Inc. to Prevail Partners on May 30, 2019 (Filed With SEC on May 11, 2020)
- Form of Securities Purchase Agreement for Series A-1 Preferred Stock (Filed With SEC on May 11, 2020)
- Investors Rights Agreement, dated September 7, 2019, among Kiromic BioPharma, Inc. and certain investors (Filed With SEC on May 11, 2020)
- Series B Preferred Stock Purchase Agreement, dated September 7, 2019, among Kiromic BioPharma, Inc. and certain investors (Filed With SEC on May 11, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on May 11, 2020)